Skip to content

Clinical trials

Completed Phase 1/2 Esophageal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1/2 Status: Completed Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20042
20051
20074
20083
20092
20101
20122
20132
20142
20153
20163
20173
20184
20191
20201
20211
20223
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
Memorial Sloan Kettering Cancer Center3
Chinese Academy of Medical Sciences2
Hokkaido Gastrointestinal Cancer Study Group2
Seagen Inc.2
Tokyo University2
Amgen1
Brian Czito1
CRISPR Therapeutics AG1
Cancer Research UK1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms49
Stomach Neoplasms16
Carcinoma, Non-Small-Cell Lung12
Ovarian Neoplasms10
Pancreatic Neoplasms10
Breast Neoplasms8
Urinary Bladder Neoplasms8
Uterine Cervical Neoplasms8
Head and Neck Neoplasms7
Prostatic Neoplasms7

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.